- Home
- BMR vs BYSI Comparison
BMR vs BYSI Comparison
Compare BMR & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- BYSI
- Stock Information
- Founded
- BMR 2009
- BYSI 2010
- Country
- BMR Israel
- BYSI United States
- Employees
- BMR N/A
- BYSI N/A
- Industry
- BMR Computer Software: Prepackaged Software
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- BMR Technology
- BYSI Health Care
- Exchange
- BMR Nasdaq
- BYSI Nasdaq
- Market Cap
- BMR 59.3M
- BYSI 71.0M
- IPO Year
- BMR 2023
- BYSI 2017
- Fundamental
- Price
- BMR $3.35
- BYSI $2.23
- Analyst Decision
- BMR
- BYSI
- Analyst Count
- BMR 0
- BYSI 0
- Target Price
- BMR N/A
- BYSI N/A
- AVG Volume (30 Days)
- BMR 1.0M
- BYSI 152.4K
- Earning Date
- BMR 08-05-2025
- BYSI 08-11-2025
- Dividend Yield
- BMR N/A
- BYSI N/A
- EPS Growth
- BMR N/A
- BYSI N/A
- EPS
- BMR N/A
- BYSI N/A
- Revenue
- BMR $3,064,000.00
- BYSI N/A
- Revenue This Year
- BMR $21.21
- BYSI N/A
- Revenue Next Year
- BMR N/A
- BYSI N/A
- P/E Ratio
- BMR N/A
- BYSI N/A
- Revenue Growth
- BMR 5.33
- BYSI N/A
- 52 Week Low
- BMR $1.86
- BYSI $0.98
- 52 Week High
- BMR $6.59
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- BMR 59.12
- BYSI 46.60
- Support Level
- BMR $2.98
- BYSI $2.33
- Resistance Level
- BMR $3.20
- BYSI $2.50
- Average True Range (ATR)
- BMR 0.22
- BYSI 0.32
- MACD
- BMR -0.01
- BYSI -0.10
- Stochastic Oscillator
- BMR 88.33
- BYSI 1.59
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.